Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat

Hims & Hers Health Inc. HIMS reported its fourth-quarter results after Monday's closing bell. Here's a look at the key figures from the quarter. 

The Details: Hims & Hers Health reported quarterly GAAP earnings of 11 cents per share, which met the analyst consensus estimate. Quarterly revenue came in at $481.14 million, which beat the analyst consensus estimate of $470.31 million and is an increase over revenue of $246.62 million from the same period last year.

Hims & Hers subscribers grew to 2.2 million, up 45% year-over-year in 2024. Gross margin was 77% for the fourth quarter of 2024 compared to 83% for the fourth quarter of 2023.

Read Next: Palantir Extends Losses, Microsoft Slides: What’s Driving Markets Monday? 

“2024 was a fantastic year at Hims and Hers as we continue to build a platform that leverages personalization and technology unlike any traditional healthcare system,” said Andrew Dudum, Hims & Hers Health CEO.

“Over 2 million subscribers now entrust Hims & Hers to aid them in their journey to better health — with thousands more joining daily,” Dudum added.

Outlook: For the first quarter of 2025, Hims and Hers expects revenue of $520 million to $540 million and adjusted EBITDA of $55 million to $65 million, reflecting an adjusted EBITDA margin of 11% to 12%.

For the full year 2025, the company expects revenue of $2.3 billion to $2.4 billion and adjusted EBITDA of $270 million to $320 million, reflecting an adjusted EBITDA margin of 12% to 13%.

HIMS Price Action: According to data from Benzinga Pro, Hims & Hers Health shares are down 17.66% after hours at $42.25 Monday.  

Read Next: 

• Financial Crime Weekly: $1.4 Billion Ethereum Stolen In Largest Crypto Hack Ever, SEC Creates Cyber And Emerging Technologies Unit

Image: Shutterstock